Cas:190001-40-2 tert-butyl 4-(2-chloroacetyl)piperazine-1-carboxylate manufacturer & supplier

Chemical Name:tert-butyl 4-(2-chloroacetyl)piperazine-1-carboxylate

CAS.NO:190001-40-2

Synonyms:1-tert-butoxycarbonyl-4-chloroacetylpiperazine;4-Chloroacetyl-piperazine-1-carboxylic acid tert-butyl ester;1-Boc-4-chloroacetyl-piperazine

Molecular Formula:C₁₁H₁₉ClN₂O₃

Molecular Weight:262.73300

HS Code:2933599090

Physical and Chemical Properties:

Melting point:99-100ºC

Boiling point:379.9ºC at 760mmHg

Density:1.203g/cm3

Index of Refraction:1.501

PSA:49.85000

Exact Mass:262.10800

LogP:1.18030

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1-tert-butoxycarbonyl-4-chloroacetylpiperazine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-Boc-4-chloroacetyl-piperazine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-tert-butoxycarbonyl-4-chloroacetylpiperazine Use and application,4-Chloroacetyl-piperazine-1-carboxylic acid tert-butyl ester technical grade,usp/ep/jp grade.

Related News: Some experts said that in the research and development of chemical medicine, the possibility of large medicines is getting smaller and smaller, and with the popularization of precision treatment, small medicines (high-efficiency medicines) are being introduced more and more. tert-butyl 4-(2-chloroacetyl)piperazine-1-carboxylate manufacturer Refers to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs or innovative drugs). It mainly meets the needs of international original research drug companies and emerging biopharmaceutical companies for innovative drugs at various stages of clinical research, registration approval and commercialization of drugs. Contains advanced intermediates used in the manufacture of this drug substance that need to be regulated by regulatory authorities. tert-butyl 4-(2-chloroacetyl)piperazine-1-carboxylate supplier The vaccine significantly reduced — by 58% — the accumulation of neurofilament light chain in the blood. This is an important biomarker of neurodegenerative diseases, Novak said — damaged nerve cells release the substance, which leaks into the blood. tert-butyl 4-(2-chloroacetyl)piperazine-1-carboxylate vendor The move could force international drugmakers to further cut prices and enable copycat medicines to replace imported off-patent brands at faster pace. tert-butyl 4-(2-chloroacetyl)piperazine-1-carboxylate factory Some experts said that in the research and development of chemical medicine, the possibility of large medicines is getting smaller and smaller, and with the popularization of precision treatment, small medicines (high-efficiency medicines) are being introduced more and more.